• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在冠状动脉搭桥术血管成形术血运重建研究(BARI)中,五年后,作为心绞痛病因,原位冠状动脉疾病进展超过血运重建失败。

Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI).

作者信息

Alderman Edwin L, Kip Kevin E, Whitlow Patrick L, Bashore Thomas, Fortin Donald, Bourassa Martial G, Lesperance Jacques, Schwartz Leonard, Stadius Michael

机构信息

Cardiovascular Division, Stanford University, Stanford, California, USA.

出版信息

J Am Coll Cardiol. 2004 Aug 18;44(4):766-74. doi: 10.1016/j.jacc.2004.05.041.

DOI:10.1016/j.jacc.2004.05.041
PMID:15312856
Abstract

OBJECTIVES

Coronary angiograms obtained five years following revascularization were examined to assess the extent of compromise in myocardial perfusion due to failure of revascularization versus progression of native disease.

BACKGROUND

The Bypass Angioplasty Revascularization Investigation (BARI) randomized revascularization candidates between bypass surgery and angioplasty. Entry and five-year angiograms from 407 of 519 (78%) patients at four centers were analyzed.

METHODS

Analysis of the distribution of coronary vessels and stenoses provided a measure of myocardial jeopardy that correlates with presence of angina. The extent to which initial benefits of revascularization were undone by failed revascularization versus native disease progression was assessed.

RESULTS

Myocardial jeopardy fell following initial revascularization, from 60% to 17% for percutaneous coronary intervention (PCI)-treated patients compared with 60% to 7% for coronary artery bypass graft (CABG) surgery patients (p < 0.001), rebounding at five years to 25% for PCI and 20% for surgery patients (p = 0.01). Correspondingly, angina prevalence was higher at five years in PCI-treated patients than in surgery-treated patients (28% vs. 18%; p = 0.03). However, myocardial jeopardy at five years, and not initial treatment (PCI vs. surgery), was independently associated with late angina. Increased myocardial jeopardy from entry to five-year angiogram occurred in 42% of PCI-treated patients and 51% of CABG-treated patients (p = 0.06). Among the increases in myocardial jeopardy, two-thirds occurred in previously untreated arteries.

CONCLUSIONS

Native coronary disease progression occurred more often than failed revascularization in both PCI- and CABG-treated patients as a cause of jeopardized myocardium and angina recurrence. These results support intensive postrevascularization risk-factor modification.

摘要

目的

检查血运重建术后五年获得的冠状动脉造影,以评估因血运重建失败与原发病进展导致的心肌灌注受损程度。

背景

旁路血管成形血运重建术研究(BARI)将血运重建候选者随机分为接受旁路手术和血管成形术两组。对四个中心519例患者中的407例(78%)患者的入院时及五年时的血管造影进行了分析。

方法

分析冠状动脉血管和狭窄的分布情况,以衡量与心绞痛存在相关的心肌危险程度。评估了血运重建失败与原发病进展相比,使血运重建的初始益处丧失的程度。

结果

初始血运重建后心肌危险程度降低,经皮冠状动脉介入治疗(PCI)患者从60%降至17%,冠状动脉旁路移植术(CABG)患者从60%降至7%(p<0.001),五年时反弹,PCI患者升至25%,手术患者升至20%(p = 0.01)。相应地,PCI治疗患者五年时心绞痛患病率高于手术治疗患者(28%对18%;p = 0.03)。然而,五年时的心肌危险程度而非初始治疗(PCI与手术)与晚期心绞痛独立相关。42%的PCI治疗患者和51%的CABG治疗患者从入院到五年血管造影时心肌危险程度增加(p = 0.06)。在心肌危险程度增加的患者中,三分之二发生在先前未治疗的动脉。

结论

在PCI和CABG治疗的患者中,作为心肌危险和心绞痛复发的原因,原冠状动脉疾病进展比血运重建失败更常见。这些结果支持强化血运重建术后危险因素的调整。

相似文献

1
Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI).在冠状动脉搭桥术血管成形术血运重建研究(BARI)中,五年后,作为心绞痛病因,原位冠状动脉疾病进展超过血运重建失败。
J Am Coll Cardiol. 2004 Aug 18;44(4):766-74. doi: 10.1016/j.jacc.2004.05.041.
2
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI).在搭桥血管成形术血运重建研究(BARI)中,血运重建范围与一年时心绞痛的关系。
J Am Coll Cardiol. 1999 Nov 15;34(6):1750-9. doi: 10.1016/s0735-1097(99)00406-4.
3
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.再次血运重建的差异是否解释了搭桥手术与经皮冠状动脉介入治疗相比的抗心绞痛益处?对未来治疗比较的启示。
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):267-75. doi: 10.1161/CIRCOUTCOMES.111.964585. Epub 2012 Apr 10.
4
Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).旁路血管成形血运重建研究2糖尿病试验(BARI 2D)中的基线冠状动脉造影结果。
Am J Cardiol. 2009 Mar 1;103(5):632-8. doi: 10.1016/j.amjcard.2008.11.024. Epub 2009 Jan 12.
5
Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).在接受当代药物治疗(无论是否及时血运重建)的 2 型糖尿病合并冠心病患者中,性别对临床表现和结局的影响:来自 BARI 2D 试验(Bypass Angioplasty Revascularization Investigation 2 Diabetes)的报告。
J Am Coll Cardiol. 2013 Apr 30;61(17):1767-76. doi: 10.1016/j.jacc.2013.01.062. Epub 2013 Feb 28.
6
Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.既往接受冠状动脉旁路移植术患者的自身冠状动脉与旁路移植血管行经皮冠状动脉介入治疗的比较。
Cardiovasc Revasc Med. 2009 Apr-Jun;10(2):103-9. doi: 10.1016/j.carrev.2008.12.002.
7
Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study.当代经皮冠状动脉介入治疗与球囊血管成形术治疗多支冠状动脉疾病的比较:美国国立心肺血液研究所动态注册研究与旁路血管成形术血运重建调查(BARI)研究的对比
Circulation. 2002 Sep 24;106(13):1627-33. doi: 10.1161/01.cir.0000031570.27023.79.
8
Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.冠状动脉疾病治疗选择中风险与获益的权衡。经皮冠状动脉介入治疗和冠状动脉旁路移植术前瞻性随机临床试验的经验教训。
Minerva Cardioangiol. 2003 Oct;51(5):585-97.
9
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI).对于适合冠状动脉旁路移植手术的非糖尿病患者,意向性不完全经皮腔内冠状动脉血管成形术血运重建策略是否可接受?旁路血管成形术血运重建调查(BARI)。
J Am Coll Cardiol. 1999 May;33(6):1627-36. doi: 10.1016/s0735-1097(99)00077-7.
10
Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery.孤立性左前降支近端病变:经皮冠状动脉介入治疗与冠状动脉旁路移植术疗效比较
JACC Cardiovasc Interv. 2008 Oct;1(5):483-91. doi: 10.1016/j.jcin.2008.07.001.

引用本文的文献

1
Predictors of secondary revascularization after coronary artery bypass graft surgery and role of dual antiplatelet therapy.冠状动脉旁路移植术后二次血运重建的预测因素及双联抗血小板治疗的作用。
J Cardiothorac Surg. 2025 Apr 16;20(1):197. doi: 10.1186/s13019-025-03434-6.
2
Cardiac Computed Tomography in Monitoring Revascularization.心脏计算机断层扫描在监测血运重建中的应用
J Clin Med. 2023 Nov 15;12(22):7104. doi: 10.3390/jcm12227104.
3
Assessment of the Graft Quality and Patency during and after Coronary Artery Bypass Grafting.冠状动脉旁路移植术中及术后移植物质量和通畅性的评估
Diagnostics (Basel). 2023 May 29;13(11):1891. doi: 10.3390/diagnostics13111891.
4
Bifurcation functional significance score as predictor of mortality: a validating study.分叉功能意义评分作为死亡率的预测指标:验证研究。
Sci Rep. 2021 Dec 21;11(1):24308. doi: 10.1038/s41598-021-03815-6.
5
The risk for subsequent coronary interventions in a local Polish population.波兰当地人群后续进行冠状动脉介入治疗的风险。
Postepy Kardiol Interwencyjnej. 2020 Dec;16(4):429-435. doi: 10.5114/aic.2020.101768. Epub 2020 Dec 29.
6
The Prognostic Value and Clinical Use of Myocardial Perfusion Scintigraphy in Asymptomatic Patients after Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后无症状患者中心肌灌注显像的预后价值及临床应用
Arq Bras Cardiol. 2018 Dec;111(6):784-793. doi: 10.5935/abc.20180199.
7
An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes).综合生物标志物风险评分可预测近期心肌梗死和死亡的高危风险:来自 BARI 2D(旁路血管成形术血运重建调查 2 型糖尿病)的研究结果。
J Am Heart Assoc. 2017 Jul 3;6(7):e003587. doi: 10.1161/JAHA.116.003587.
8
Preventing graft restenosis after coronary artery bypass grafting with tissue-type plasminogen activator.用组织型纤溶酶原激活剂预防冠状动脉旁路移植术后移植物再狭窄。
Eur J Med Res. 2017 Jun 12;22(1):18. doi: 10.1186/s40001-017-0259-8.
9
Factors Associated With Coronary Artery Disease Progression Assessed By Serial Coronary Computed Tomography Angiography.通过系列冠状动脉计算机断层扫描血管造影评估的与冠状动脉疾病进展相关的因素。
Arq Bras Cardiol. 2017 May;108(5):396-404. doi: 10.5935/abc.20170049. Epub 2017 May 4.
10
Prediction of fractional flow reserve with angiographic DILEMMA score.利用血管造影DILEMMA评分预测血流储备分数
Anatol J Cardiol. 2017 Apr;17(4):285-292. doi: 10.14744/AnatolJCardiol.2016.7379. Epub 2016 Nov 10.